Barrier to Adoption: Uncertainty About Sample Requirements

Interesting survey (sponsored by Boehringer Ingelheim) of pulmonologists and pathologists regarding barriers to adoption of biomarker testing of lung cancer patients. Key finding: “Both pulmonologists and pathologists said the biggest challenges with biomarker...